BCLC Stage B Hepatocellular Carcinoma
15 clinical trials · Condition
◉ Watch BCLC Stage B Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy (NCT05250895) | Emory University | 2022-04-28 |
| Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer (NCT04828486) | Mayo Clinic | 2021-08-17 |
| Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer (NCT04605731) | City of Hope Medical Center | 2021-08-03 |
| Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer (NCT04442581) | University of Washington | 2021-04-20 |
| The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer (NCT04204577) | Chinese PLA General Hospital | 2019-11-01 |
| Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (NCT02940496) | M.D. Anderson Cancer Center | 2016-12-09 |
Track BCLC Stage B Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.